Bariatric metabolic surgery is associated with a lower risk for heart failure versus GLP-1RAs

Yael Wolff Sagy, Orna Reges

Research output: Contribution to journalComment/debate

Abstract

In an observational cohort study of adults living with obesity and diabetes, we found that the primary incidence of congestive heart failure was lower in patients treated with bariatric metabolic surgery than in those on first-generation GLP-1 receptor agonists, an effect that was not explained by greater weight loss in the group that received bariatric metabolic surgery.

Original languageEnglish
Pages (from-to)2417-2418
Number of pages2
JournalNature Medicine
Volume30
Issue number9
DOIs
StatePublished - Sep 2024

Fingerprint

Dive into the research topics of 'Bariatric metabolic surgery is associated with a lower risk for heart failure versus GLP-1RAs'. Together they form a unique fingerprint.

Cite this